The Mediterranean diet is not a specific diet plan or diet program. Rather, it’s a collection of eating habits that are traditionally followed by the people of the Medierranean region. The Mediterranean diet has attracted interest due to the traditionally lower rates of diet-related disease (e.g. heart disease and cancer) within the region.
Vitamin E supplements do not protect healthy women against heart attacks and stroke, according to new results from the Women?s Health Study, a long-term clinical trial of the effect of vitamin E and aspirin on both the prevention of cardiovascular disease and of cancer.
The complications of Rheumatic Arthritis are much more dangerous & tedious to cure.According to advanced research performed on Homoeopathic medicinal potencies it is possible to cure stenosis of mitral & aortic valves completely with the help of only HIGHLY QUALITATIVE HOMOEOPATHIC MEDICINE.
A Stanford University School of Medicine study using new measures of heart disease risk shows that gastric bypass surgery reduces the risk of heart disease even more than previously believed. The researchers say the finding underscores the value of the surgery for extremely overweight people, whose obesity puts them in danger of heart attack, stroke and other cardiovascular illness.
Scientists in Hong Kong have shed new light on why cell repair is less efficient in older people after a breakthrough discovery on premature aging, a rare genetic disease that affects one in four million babies.
In people with diabetes, diuretics work as well as ACE-inhibitors and calcium channel blockers in protecting against heart attack and improving survival, and offer more protection against congestive heart failure.
The Food and Drug Administration (FDA) approved BiDil (bye-DILL), a drug for the treatment of heart failure in self-identified black patients, representing a step toward the promise of personalized medicine.
The Food and Drug Administration (FDA) announced the approval of Aptivus (tipranavir) capsules, an HIV protease inhibitor, to be given with ritonavir for treatment of HIV-1 infected adults. This is the second drug approved for patients with advanced HIV disease, and provides a new therapy for patients with limited treatment options.
Diabetic retinopathy has been found in nearly 8 percent of pre-diabetic participants in the Diabetes Prevention Program (DPP), according to a report presented today at the American Diabetes Association’s 65th Annual Scientific Sessions. Diabetic retinopathy, which can lead to vision loss, was also seen in 12 percent of participants with type 2 diabetes who developed diabetes during the DPP. No other long-term study has evaluated retinopathy in a population so carefully examined for the presence or development of type 2 diabetes.
A significantly lower risk of heart disease can now be added to the list of proven long-term benefits of tight glucose control in people with type 1 diabetes. Researchers announced this finding today at the annual scientific meeting of the American Diabetes Association after analyzing cardiovascular (CVD) events such as heart attack, stroke, and angina in patients who took part in the Diabetes Control and Complications Trial (DCCT) years ago.